MedKoo Cat#: 414698 | Name: Oxycardin

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Oxycardin is in a group of drugs called nitrates. Oxycardin dilates (widens) blood vessels, making it easier for blood to flow through them and easier for the heart to pump. Oxycardin is used to prevent angina attacks (chest pain). Oxycardin will not treat an angina attack that has already begun.

Chemical Structure

Oxycardin
Oxycardin
CAS#67970-62-1

Theoretical Analysis

MedKoo Cat#: 414698

Name: Oxycardin

CAS#: 67970-62-1

Chemical Formula: C20H31Cl2N3O10

Exact Mass: 543.1386

Molecular Weight: 544.38

Elemental Analysis: C, 44.13; H, 5.74; Cl, 13.02; N, 7.72; O, 29.39

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Oxycardin
IUPAC/Chemical Name
(3R,3aS,6S,6aS)-hexahydrofuro[3,2-b]furan-3,6-diyl dinitrate compound with 1-(tert-butylamino)-3-(2-chloro-5-methylphenoxy)propan-2-ol (1:1) hydrochloride
InChi Key
UJQNCDJPZGORII-SADXPQEKSA-N
InChi Code
InChI=1S/C14H22ClNO2.C6H8N2O8.ClH/c1-10-5-6-12(15)13(7-10)18-9-11(17)8-16-14(2,3)4;9-7(10)15-3-1-13-6-4(16-8(11)12)2-14-5(3)6;/h5-7,11,16-17H,8-9H2,1-4H3;3-6H,1-2H2;1H/t;3-,4+,5-,6-;/m.1./s1
SMILES Code
Cc1cc(OCC(CNC(C)(C)C)O)c(Cl)cc1.[O-][N+](O[C@H]2CO[C@@H]3[C@H](O[N+]([O-])=O)CO[C@H]23)=O.Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 544.38 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Trif V, Oancea I. Wirkung bon Oxycardin auf den Augeninnendruck [Effect of oxycardin on the intraocular pressure]. Med Welt. 1978 Jun 30;29(26):1100-4. German. PMID: 27693. 2: Philipp R, Kutscha W. Zur Behandlung der Koronarinsuffizienz. Vergleichsstudie über die Wirkung eines Nitropräparates (Isosorbiddinitrat), eines Betasympathikolytikums (Bupranolol) und eines Kombinationspräparates (Oxycardin) [Treatment of coronary insufficiency. Comparative study on the effect of a nitro compound (isosorbidedinitrate), a beta sympatholytic (bupranolol) and a drug combination (oxycardin)]. Med Welt. 1980 May 23;31(21):817-20. German. PMID: 7392937. 3: Tuluweit K, Strauss G. Langzeitbehandlung der koronaren Herzkrankheit mit begleitender Hypertonie. Oxycardin retard beim Koronarhypertoniker [Long-term treatment of coronary heart disease with concomitant hypertension. Oxycardin retard in the coronary hypertensive patient]. ZFA (Stuttgart). 1983 Mar 10;59(7):388-94. German. PMID: 6845862. 4: Hoffmann J. Die Behandlung der koronaren Herzkrankheit. Oxycardin retard bei gleichzeitig bestehender arterieller Hypertonie [Treatment of coronary heart disease. Oxycardin retard in simultaneously existing arterial hypertension]. Fortschr Med. 1983 Apr 28;101(16):764-7. German. PMID: 6852752. 5: Oancea I. Wirkung von Oxycardin im Akutversuch auf den Augeninnendruck von Patienten mit chronischem Glaucoma simplex [The immediate effect of beta-isoket on the internal ocular pressure in patients with chronic simple glaucoma (author's transl)]. Klin Monbl Augenheilkd. 1975 Oct;167(4):618-22. German. PMID: 1574.